Total Receivables - Diffusion Pharmaceuticals Inc (NASDAQ:CRVO) - Alpha Spread
D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 17.47 USD 10.57% Market Closed
Market Cap: 144.2m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Diffusion Pharmaceuticals Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Total Receivables
$915.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.7B
CAGR 3-Years
6%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.7B
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$5.7B
CAGR 3-Years
-7%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is Diffusion Pharmaceuticals Inc's Total Receivables?
Total Receivables
915.4k USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Total Receivables amounts to 915.4k USD.

Back to Top